# Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/overall-survival-in-patients-with-endometrial-cancer-treated-with-dostarlimab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | M.A. Powell,Line Bjørge,Lyndsay Willmott,Z. Novák,D. Black,L. Gilbert,S. Sharma,G. Valabrega,Lisa M. Landrum,Martina Gropp‐Meier,A. Stuckey,Ingrid Boere,Michael A. Gold,Yakir Segev,S.E. Gill,Christine Gennigens,Alexandra Sebastianelli,Mark S. Shahin,Bhavana Pothuri,B.J. Monk,Joseph Buscema,R.L. Coleman,B.M. Slomovitz,Kari L. Ring,T.J. Herzog,Morad Marco Balas,M. Grimshaw,S. Stevens,Dominic W. Lai,Carolyn K. McCourt,MR Mirza |
| Citations | 112 |
| DOI | 10.1016/j.annonc.2024.05.546 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.annalsofoncology.org/article/S092375342400721X/pdf |
| OpenAlex ID | https://openalex.org/W4399508081 |
| PMID | 38866180 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Yakir Segev](https://scholariq.org/researchers/yakir-segev/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

## Paper topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.